AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05516732 — intervention group
Intervention type: OTHER
Intervention: FP-CIT Single-photon Emission Computed Tomography (SPECT) scan
Description: A single-photon emission computerized tomography (SPECT) scan allows analysis of brain function by creating 3D Pictures using compounds called tracers.
Study NCT05516732 — intervention group
Intervention type: OTHER
Intervention: Lumbar puncture
Description: A lumbar puncture invovles a thin needle is inserted between the bones in your lower spine using local anaesthetic. This allows the collection of Cerebrospinal fluid ( CSF)
Study NCT05888545 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: anti-adhesion diaphragm
Description: Participants will be asked to place an anti-adhesion diaphragm in the uterus for 3-7 days after the abortion procedure.
Study NCT05466916 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise and diet education and instruction
Description: 1:1 or small group sessions consisting of educational materials and exercise instruction.
Study NCT05175586 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: First data analysis
Description: A series of questions were asked to a number of patients with diagnoses related to primary idiopathic stiff shoulder and/or extrinsic stiff shoulder secondary to trauma or surgery. These patients are part of the physiotherapy clinic receiving the research. This questionnaire answers basic questions for the structure of the study such as age and sex, physical behaviour during the week, endurance, athletic disability, reason for attending the clinic, exploratory motor tests, etc. Subsequently, physiotherapeutic tests related to the pathology within the research were performed consisting of joint range, percentage of shoulder disability and pain scale.
Study NCT05175586 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: First data analysis
Description: A series of questions were asked to a number of patients with diagnoses related to primary idiopathic stiff shoulder and/or extrinsic stiff shoulder secondary to trauma or surgery. These patients are part of the physiotherapy clinic receiving the research. This questionnaire answers basic questions for the structure of the study such as age and sex, physical behaviour during the week, endurance, athletic disability, reason for attending the clinic, exploratory motor tests, etc. Subsequently, physiotherapeutic tests related to the pathology within the research were performed consisting of joint range, percentage of shoulder disability and pain scale.
Study NCT05175586 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Second data analysis
Description: Three treatment sessions of Percutaneous Neuromodulation (PNM) and Orthopaedic Manual Therapy (OMT) (Maitland and Mulligan) (group 1) and three treatment sessions of Orthopaedic Manual Therapy (OMT) (Maitland and Mulligan) (group 2) were performed at a rate of two sessions per month for three months. These therapies were compared with the clinical examination performed prior to each new session to verify changes in joint range, percentage of shoulder disability, strength and pain scale.
Study NCT05175586 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Second data analysis
Description: Three treatment sessions of Percutaneous Neuromodulation (PNM) and Orthopaedic Manual Therapy (OMT) (Maitland and Mulligan) (group 1) and three treatment sessions of Orthopaedic Manual Therapy (OMT) (Maitland and Mulligan) (group 2) were performed at a rate of two sessions per month for three months. These therapies were compared with the clinical examination performed prior to each new session to verify changes in joint range, percentage of shoulder disability, strength and pain scale.
Study NCT05175586 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: database
Description: Age and sex were expressed as mean ± standard deviation (SD). The rest of the variables were expressed as mean, absolute and relative frequency. The chi-square test was used to analyse the differences between the examinations in terms of the time taken and the treatments used in the two groups. A confidence level of 95% was established, considering a value of p\<0.05 as statistically significant.
Study NCT05175586 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: database
Description: Age and sex were expressed as mean ± standard deviation (SD). The rest of the variables were expressed as mean, absolute and relative frequency. The chi-square test was used to analyse the differences between the examinations in terms of the time taken and the treatments used in the two groups. A confidence level of 95% was established, considering a value of p\<0.05 as statistically significant.
Study NCT05536687 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: FeetMe
Description: Healthy volunteers will wear the insoles at 2 visits in hospitals (D0 and D8) and 2 visits at home (D1 and D7). The visits at the hospital will be composed of 3 tests of 6 min. in various conditions in a hospital environment :~* In degraded conditions, i.e. a 10m corridor, evaluated simultaneously by the FeetMe® system and an evaluator~* In degraded condition, a 10m corridor, evaluated simultaneously by the FeetMe® system and an odometer and evaluator~* Under the conditions recommended for the 6-minute test (ref), i.e. a 30m corridor, evaluated simultaneously by the FeetMe® system and the evaluator A rest time of 15 min minimum will be respected between each test. The visits at home will be composed of a 6-minute test at home or outdoors (quiet place, flat, hard surface, few or no passages, ideally no obstacles, covered if weather conditions are not suitable) with a 10-meter track that you can define simply with equipment provided by the promoter.
Study NCT06141863 — intervention group
Intervention type: OTHER
Intervention: questionnaire
Description: Neck Disability Index, The Fonseca Anamnestic Index (FAI) and Visual Analogue Scale (VAS)
Study NCT05129540 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Custom-made foot orthosis
Description: The foot orthoses for group A will be custom made using phenolic foam molds of the feet. They consist of a polypropylene layer of 3 mm from heel to just proximal to the metatarsal heads, and an upper sheet of 30 Shore A polyethylene foam.
Study NCT05129540 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo orthosis
Description: A flat insole made of the same material as the upper layer of the custom-made foot orthoses used for group custom-made foot orthosis.
Study NCT06397573 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Reirradiation
Description: Ablative reirradiation of 50 Gy in 5 fractions (5 sessions) that will occur once per day, either for 5 days in a row, or every other day.
Study NCT06196346 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychotherapy
Description: see group description
Study NCT05490030 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TNO155
Description: Single oral dose of TNO155 on Day 1
Study NCT06069414 — intervention group
Intervention type: OTHER
Intervention: Type of anesthesia induction
Description: Patients will receive inhalatory or intravenous anesthesia at their choice; both groups will be evaluated with lung ultrasound after induction to detect ultrasonografic signs of atelectasis
Study NCT05742880 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: SHAM_COMPARATOR
Intervention: Blood gas analysis
Description: Blood gas analyisis
Study NCT05742880 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Wearing a Surgical Facemask
Description: Wearing a Surgical Facemask
Study NCT05742880 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Wearing a FFP2- Facemask
Description: Wearing a FFP2- Facemask
Study NCT05742880 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Wearing no Mask
Description: Wearing no Mask
Study NCT06552650 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Four supervised exercise interventions after surgery: One exercise education session per week from postoperative day 5 through 1 month Subsequent home-based exercise: Home-based exercise recommendations from 1 month to 3 months post-surgery
Study NCT06552650 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual Care
Description: The full spectrum of patient care practices in which clinicians have the opportunity (which is not necessarily seized) to individualize care
Study NCT06553495 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nerve block
Description: Analgesic effect of different nerve blocks
Study NCT06553495 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Nerve block
Description: Analgesic effect of different nerve blocks
Study NCT04886778 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet
Description: Participants will be instructed to maintain a daily dietary energy intake of less than 1600 kcal.Based on the low-carbohydrate diet model, the proportion of daily intake of carbohydrate was about 30%, and this ratio was up to 30%, 40% of protein and fat respectively.Participants should choose unprocessed whole grains, potatoes, vegetables, meat, fish, eggs, soy products, sugar-free dairy products, designated varieties of low-GI fruits and nuts, etc. as breakfast, and avoid processed meats and high-fat red meat and poultry skins. Standard nutritious meal instead of daily lunch and dinner meals, that is to say, participants should take one nutritional bar for lunch and dinner (310 kcal totally, provided by Guangzhou Nanda Fett Nutrition and Health Consulting Co., Ltd.), and avoid starchy foods. Other food varieties are required to be the same as breakfast. Plant oil is the main cooking oil, and participants will be instructed to drink 2L water every day.
Study NCT04886778 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Low-carbohydrate diet
Description: Participants will be instructed to maintain a daily dietary energy intake of less than 1600 kcal.Based on the low-carbohydrate diet model, the proportion of daily intake of carbohydrate was about 30%, and this ratio was up to 30%, 40% of protein and fat respectively.Participants should choose unprocessed whole grains, potatoes, vegetables, meat, fish, eggs, soy products, sugar-free dairy products, designated varieties of low-GI fruits and nuts, etc. as breakfast, and avoid processed meats and high-fat red meat and poultry skins. Standard nutritious meal instead of daily lunch and dinner meals, that is to say, participants should take one nutritional bar for lunch and dinner (310 kcal totally, provided by Guangzhou Nanda Fett Nutrition and Health Consulting Co., Ltd.), and avoid starchy foods. Other food varieties are required to be the same as breakfast. Plant oil is the main cooking oil, and participants will be instructed to drink 2L water every day.
Study NCT04886778 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic compound preparations
Description: The probiotic compound preparation，named Junyi Yili® Probiotics，is made of Lactobacillus reuteri, Lactobacillus gasseri, Lactobacillus acidophilus and Bifidobacterium lactis, and resistant dextrin contained water-soluble dietary fiber. The subjects will take this probiotic compound preparations with purified water after three meals every day, 1 sachet each time.
Study NCT04886778 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo is made of resistant dextrin which contained water-soluble dietary fiber. The subjects were taken this placebo with purified water after three meals every day, 1 sachet each time.
Study NCT05661604 — intervention group
Intervention type: OTHER
Intervention: No Intervention
Description: This is an observational study to assess the incidence and key disease characteristics of symptomatic acute respiratory viral infections in a high-risk population at risk for poor outcomes. Duration of each participant will be up to 12 months.
Study NCT03553524 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: morning HIIT --> afternoon HIIT
Description: Arm 1 will start with morning HIIT at visit 2 and afternoon HIIT at visit 3
Study NCT03553524 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: afternoon HIIT --> morning HIIT
Description: Arm 2 will start with afternoon HIIT at visit 2 and morning HIIT at visit 3
Study NCT05500963 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation
Description: Electrical stimulation applied over selected leg muscle will activate sensory receptors that will transmit signals back into the central nervous system.
Study NCT05500963 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcutaneous electrical nerve stimulation
Description: Electrical stimulation applied over selected leg muscle will activate sensory receptors that will transmit signals back into the central nervous system.
Study NCT05427240 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pre-Test Intervention
Description: Secure and accessible by private code only, the web-based intervention will provide users with a the results of their clinical genetic testing results and a detailed summary of what those results mean. Additionally, an individualized summary will also be included.
Study NCT05427240 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard of Care
Description: Standard of Care with a Genetic Counselor by Remote Services
Study NCT05427240 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Post-Test Intervention
Description: Secure and accessible by private code only, the web-based intervention will provide users with a the results of their clinical genetic testing results and a detailed summary of what those results mean. Additionally, an individualized summary will also be included.
Study NCT04655573 — intervention group
Intervention type: PROCEDURE
Intervention: Breast Cancer Tumor Resection
Description: Patients with ABC will be receiving a biopsy, and a PDMO from the patient's biopsies will be generated from it. It is a model correlating clinical response with PDMO sensitivity to the most common forms of chemotherapy used in advanced breast cancer care.
Study NCT06078059 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Knee aspiration + UCB-MSCs
Description: Knee aspiration and the application of cultered allogeneic umbilical cord blood-derived mesenchymal stromal stem cells (UCB-MSCs).
Study NCT06078059 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Knee aspiration
Description: Knee aspiration
Study NCT06722677 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VNS
Description: An neuromodulation treatment that delivers electrical impulses to the brain via the vagus nerve.
Study NCT06722677 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Sham VNS
Description: An neuromodulation treatment that delivers electrical impulses to the brain via the vagus nerve, the actual intensity is 0 mA.
Study NCT06722677 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Rehabilitation
Description: Rehabilitation movements to improve upper limb function after stroke.
Study NCT06722677 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rehabilitation
Description: Rehabilitation movements to improve upper limb function after stroke.
Study NCT06725966 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Epley maneuver
Description: Epley maneuver using a mechanized chair
Study NCT06725966 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Personalized Epley maneuver
Description: Personalized Epley maneuver, using a mechanized chair
Study NCT06725238 — intervention group
Intervention type: OTHER
Intervention: Acute-to-chronic glycemic ratio
Description: This ratio could be related to diabetic foot ulcer
Study NCT06725563 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopically placed lumen-apposing metal stents for the treatment of IBD-strictures
Description: We will apply standard procedures for endoluminal stenting. A therapeutic colonoscope will be advanced through the bowel up until the stricture. A guidewire will be passed through the lumen at the stricture site. LAMS will be used for strictures \&lt;6cm, with stents ranging in size from 10-16mm in diameter and up to 60mm in length. The stent will be deployed across the stricture with the assistance of endoscopic and fluoroscopic imaging. Individuals will undergo a repeat colonoscopy in 1-3 months to remove the stent.
Study NCT06726512 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: XEOS AURA 10
Description: Surgery is performed according to standard of care. Directly after surgery, the surgical specimen is taken outside the operation theatre in a dedicated imaging room at the Department of Nuclear Medicine where high-resolution PET-CT imaging of the surgical specimen is performed.
Study NCT06725524 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: JMT601
Description: intravenous infusion on day 1 once a week
Study NCT06726746 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser
Description: . Using the following settings with the internal handpiece: square pattern with Deep Mode, fractional density of 5% and energy level of 50 mJ and fluence of 283 J/cm2. The handpiece will be inserted into the vagina (up to 10 cm) The handpiece will be positioned with contact to the vagina and will be rotated to apply 12 pulses at each 1-cm marking (application of laser energy at 3-10-cm depths) until the distal end of the vaginal probe reaches the introitus.~The laser application will be performed on an outpatient basis without local anesthesia in outpatient clinic.
Study NCT06726538 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Intravenous administration of Autologous, adipose-derived mesenchymal stem cells
Description: Patients in group A will receive two infusions of autologous, adipose-derived mesenchymal stem cells at day 0 and day 90 ± 14 at a dose of 10\^6 cells/kg.~Autologous, adipose-derived mesenchymal stem cells used in this study were harvested from autologous fat tissue through an enzyme method and expanded using our in-house optimized serum-free and xeno-free culture under a physiological oxygen concentration of 5%. For clinical use, cells at passage 3 will be harvested in 100 mL Ringer's lactate. Therapeutic ASC products must pass the following releasing criteria: (1) negative for bacteria, fungi and mycoplasma; (2) more than 90% viability; (3) expression of more than 95% positivity for CD105, CD73, and CD90 and less than 2% positivity for CD45, CD34, CD11b, CD19, and HLA-DR; and (4) endotoxin \<5 EU/kg. The patient will be infused with 1x106 cells/kg body weight within 60 minutes via the intravenous route.
Study NCT06725095 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo gel
Description: Patients were treated with non surgical peri-implant mucositis therapy with non-surgical sub-marginal peri-implant instrumentation plus the use of a placebo gel
Study NCT06725095 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Enamel Matrix Proteins Derivative
Description: Patients were treated with non surgical peri-implant mucositis therapy with non-surgical sub-marginal peri-implant instrumentation plus the use of non-surgical treatment plus Enamel Matrix Proteins Derivative
Study NCT06726187 — intervention group
Intervention type: OTHER
Intervention: Structured Clinical Interview for DSM-5 Screening Personality Questionnaire (SCID-5-SPQ).
Description: Screening questionnaire
Study NCT06725368 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PCC
Description: PCC protocol (Paclitaxel - Carboplatin - Cetuximab) by intravenous injection for 16 cycles. 1 cycle lasts 1 week. The Carboplatin + Paclitaxel administration schedule 3 weeks out of 4, with weekly Cetuximab is authorized.~After 16 cycles: maintenance with Cetuximab 500 mg/m2 every 14 days until unacceptable toxicity or progression or death.
Study NCT06726161 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: RYZ811
Description: Ga-68
Study NCT06726161 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RYZ801
Description: Ac-225
Study NCT06727396 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-508 Tablet
Description: Investigational drug
Study NCT06582654 — intervention group
Intervention type: DEVICE
Intervention: Sampling
Description: Collection of first-void urine (i.e. the initial stream of the urine) with the Colli-Pee device (Novosanis, Belgium) (6-21 samples over a period of 36 days).~Collection of blood samples (2 samples, at day 1 and 36 of the study).
Study NCT06582082 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pulmonary rehabilitation
Description: The study group will receive pulmonary rehabilitation
Study NCT06582082 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: pursed lip breathing
Description: the control group will stick to pursed lip breathing only
Study NCT06727396 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Tablet
Description: Placebo
Study NCT04406064 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Viral Specific T-cells (VSTs)
Description: VSTs will be infused into study participants who have evidence of SARS-CoV-2 infection.
Study NCT04782908 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcatheter tricuspid valve edge-to-edge repair
Description: Transcatheter tricuspid valve edge-to-edge repair is an interventional approach to treat severe tricuspid regurgitation. Under general anesthesia a clip delivery system is forwarded through the vena femoralis and right atrium in the right ventricle. A clip is deployed to clamp the tricuspid valve and reduce tricuspid valve regurgitation.